COMMUNIQUÉS West-GlobeNewswire

Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
15/04/2026
Expanded treatment in community settings will reduce patient burden Option to redose patients granted in both Ntrust-1 and Ntrust-2 studies Rheumatoid arthritis cohort to be added to Ntrust-2 Dosing continues at 4 [...]
Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026
15/04/2026
SEATTLE, April 15, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
Inteleos Foundation annonce les lauréats du Prix MedMissions 2026 pour renforcer l’accès à l’échographie maternelle dans cinq nations
15/04/2026
ROCKVILLE, Maryland, 15 avr. 2026 (GLOBE NEWSWIRE) -- La Inteleos Foundation a annoncé aujourd’hui les cinq organisations bénéficiaires de son Prix MedMissions 2026, une initiative visant à améliorer l’accès à l’ [...]
Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting
15/04/2026
Allschwil, Switzerland, April 15, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal [...]
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 40 Million
15/04/2026
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE [...]
Annual General Meeting 2026: Tecan shareholders endorse all motions proposed by the Board of Director including stable dividend of CHF 3.00 per share
15/04/2026
Annual General Meeting 2026: Tecan shareholders endorse all motions proposed by the Board of Director including stable dividend of CHF 3.00 per share Männedorf, Switzerland, April 15, 2026 – The Annual General Meeting [...]
AssureCKD Appoints Former LumiraDx Technical Director Dr. Aman Khan as Chief Technology Officer to Lead Diagnostic Platform Development
15/04/2026
VANCOUVER, British Columbia, April 15, 2026 (GLOBE NEWSWIRE) -- AssureCKD , a Canadian medical device company developing point-of-care solutions for chronic kidney disease (CKD) screening and diagnosis, today announced [...]
Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer
15/04/2026
Ms. Deardorf is an experienced biopharma leader who will lead business development and corporate and commercial strategy as Neutrolis advances NTR-1011 into autoimmune diseases following positive Phase 1a results [...]
Calidi Biotherapeutics Announces Participation in RedChip’s April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
15/04/2026
SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will [...]
Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions
15/04/2026
Adare Partnership Provides Supply Chain Redundancy and U.S.-based Manufacturing Capability Company Reiterates Guidance - If Approved, Cytisinicline Commercial Launch Expected in First Half of 2027 SEATTLE and VANCOUVER [...]
SAB BIO to Present Additional Data Supporting the Unique Profile of SAB-142 at the 2026 Immunology of Diabetes Society Congress
15/04/2026
MIAMI, April 15, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and [...]
Folia Health Launches “BRAVE-PWS” Study to Better Understand the Real-World Experience of Prader-Willi Syndrome Caregivers
15/04/2026
BOSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Folia Health announces the launch of Burden and Real-world Assessment of Caregiver Voice and Experiences in Prader-Willi syndrome (BRAVE-PWS), a fully remote observational [...]
BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026
15/04/2026
MENLO PARK, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, [...]
HealPort Raises 1.2M USD to Scale Global Digital Health Infrastructure
15/04/2026
MUSCAT, Oman, April 15, 2026 (GLOBE NEWSWIRE) -- HealPort announced that it has raised $1.2 million in funding to accelerate development and deployment of its integrated platforms and supporting infrastructure designed [...]
Ardena Opens New Bioanalytical Laboratory in Somerset, New Jersey
15/04/2026
Somerset, New Jersey, USA – April 15, 2026 – Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces that its new state-of –the-art GLP bioanalytical [...]
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
15/04/2026
Travelers can now purchase the only once-weekly, broad-spectrum malaria preventive online, through the Runway Health telehealth platform WASHINGTON, April 15, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. ( [...]
Reviva Announces Letter to Shareholders
15/04/2026
CUPERTINO, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva,” the “Company” “we” or “us”), a late-stage pharmaceutical company developing therapies that seek to [...]
Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
15/04/2026
Study in a well-accepted mouse model of severe Tuberous Sclerosis Complex (TSC) showed that simufilam attenuated the progression of seizures in a dose-dependent manner Results confirm and extend previously published [...]
Allogene Therapeutics Announces Nature Communications Publication Highlighting Pre-Clinical Data for ALLO-329, a Next Generation Dual-Targeted CD19/CD70 Allogeneic CAR T for Autoimmune Diseases
15/04/2026
Study Highlights Dagger ® Technology Showing that an Optimized CD70 CAR has the Potential to Protect Against Immune Rejection, Enabling Robust Expansion and Persistence of Allogeneic CAR T Cells in Pre-Clinical Models [...]

Pages